Jeah Jung, PhD

Articles

June 14th 2019

Cancer Care Spending and Use by Site of Provider-Administered Chemotherapy in Medicare

Andrew Shooshtari, BS Yamini Kalidindi, MHA Jeah Jung, PhD

Differences in cancer care spending and utilization between Medicare beneficiaries receiving chemotherapy in hospital outpatient departments versus physician offices vary by service type.

October 4th 2018

The Authors Respond and Stand Behind Their Findings

Yamini Kalidindi, MHA Jeah Jung, PhD Roger Feldman, PhD

Our study provides the first evidence on site-specific Medicare spending on chemotherapy adjusting for patient comorbid illnesses, cancer type, and other cancer-related risks.

July 19th 2018

Differences in Spending on Provider-Administered Chemotherapy by Site of Care in Medicare

Yamini Kalidindi, MHA Jeah Jung, PhD Roger Feldman, PhD

Spending on chemotherapy drugs was lower among Medicare beneficiaries who received chemotherapy in hospital outpatient departments than among comparable beneficiaries receiving chemotherapy in physician offices.

September 18th 2017

In-Gap Discounts in Medicare Part D and Specialty Drug Use

Jeah Jung, PhD Wendy Yi Xu, PhD Chelim Cheong, PhD

This study examined the early impacts of closing the donut hole in Medicare Part D.